Member Log In

News from our community

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • 14 Jul 2022 7:53 AM | Anonymous member (Administrator)

    Higher Orbits will launch its final event of the BRPH Series, Go For Launch! Alabamanext week running July 20-22, thanks to stellar support from their Series Sponsor.

    The hands-on flagship program of Higher Orbits spotlights the wonders of spaceflight and space exploration to provide students across the country the opportunity to develop and strengthen their skills in STEM, teamwork, communication, research design, and leadership. While focusing on spaceflight, Go For Launch! students work alongside a featured astronaut at each event to learn and develop important skills that can be applied in any professional field.

    Read the full article HERE.

  • 5 Jul 2022 3:00 PM | Anonymous member (Administrator)

    Eurofins Discovery acquired DiscoveryBioMed for its expertise in leveraging primary and immortalized human diseased and normal cells to develop novel, customized bioassays supporting clients from HTS to lead optimization. DiscoveryBioMed achieves this through its focus on biologically relevant cellular models for the renal, skin, taste, ophthalmic, liver, respiratory, oncology, and other therapeutic areas. The addition of DiscoveryBioMed supports Eurofins Discovery's strategy to have the most complete, highest quality portfolio of drug discovery services and products, and further strengthens its ability to support translational biology for drug discovery research and development.

    Read full article here.

  • 27 Jun 2022 12:17 PM | Anonymous member (Administrator)

    Good news for our members who work on developing innovative cancer-detection technologies. Rep. Terri Sewell announced on June 23 that the Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 1946) has achieved a significant milestone, earning the support of a bipartisan majority of members in the U.S. House of Representatives. 

    The legislation clears the way for coverage of Multi-Cancer Early Detection blood tests, which have the potential to shift how cancer is screened for and detected. 

    Many thanks to Rep. Sewell, the legislation’s lead sponsor, for leading the charge on H.R. 1946 and being a champion for innovation!

    Check out the full article below.

  • 20 Jun 2022 5:53 PM | Anonymous member (Administrator)

    A University of Alabama at Birmingham biotech startup received $1.2 million to continue research toward treating a chronic kidney disease.

    Reliant Glycosciences LLC received a National Institutes of Health Small Business Innovation Research Phase II award to continue the development of its IgA nephropathy-related biomarker assays. The award runs through spring 2024.

    Read full article HERE.

  • 14 Jun 2022 3:39 PM | Anonymous member (Administrator)

    UAB start-up SunFire Biotechnologies LLC was awarded a grant by the U.S. Department of Defense to continue advancing an assay to support the development of Shigella vaccines.

    The Phase II Small Business Innovation Research (SBIR) grant is for approximately $1 million over two years, and will assist SunFire researchers in qualifying and validating the assay so that SunFire can function as a contract research organization for other companies that are developing Shigella vaccines.

    Read full article HERE.

  • 14 Jun 2022 3:37 PM | Anonymous member (Administrator)

    A local ag tech firm recently raised $5.78 million in seed round funding. 

    Chonex will use the funds to expand production capacity and meet rising demand as well as to file patent applications for its proprietary process. Funding was led by undisclosed Alabama finance, manufacturing and engineering leaders.

    Read full article HERE.

  • 14 Jun 2022 2:53 PM | Anonymous member (Administrator)

    Astound, a Birmingham-based startup, has successfully secured $1m in seed funding to develop the first marketplace to allow research institutions and universities to easily find corporate sponsors for important scientific research.

    Read the full article here.

  • 3 May 2022 9:33 AM | Anonymous member (Administrator)

    BIO Alabama focusing on future of bioscience industry in state

  • 29 Apr 2022 9:32 AM | Anonymous member (Administrator)

    Madison Core Laboratories Announces Huntsville Laboratory Expansion


    HUNTSVILLE, AL - Madison Core Laboratories (“MCL”) is pleased to announce the expansion of its clinical laboratory in Huntsville, Alabama. “This expansion increases our laboratory space by approximately 50 percent and will allow MCL to enhance its comprehensive diagnostic testing product lines and launch additional innovative services to better the lives of the patients we serve,” commented Carlo Crespo, MD, Chief Executive Officer.


    Phase 1 of the Huntsville Lab expansion will be the integration of core laboratory services currently being performed in the Madison facility. These services include chemistry, hematology, coagulation, and urinalysis testing. By integrating these laboratory services into the Huntsville location, MCL will be able to achieve greater efficiencies and provide its clients and patients with expanded high-quality testing with faster turnaround times. The expanded laboratory footprint allowed for the immediate addition of several new instrumentation systems. Further automated instrumentation platforms will be added in the coming months.


    This phase will also provide a new and larger area for specimen receipt, accessioning, and processing, and more space to support the growth of the Company’s onsite phlebotomy services. Current facility development also underway is the addition of administrative offices and a new streamlined laboratory storage system.


    “Having our core laboratory team under the same roof as our molecular, microbiology, and toxicology teams will also provide a better work environment for our employees that supports greater communication, increased team collaboration, and opportunities for cross-training, and sharing collective intelligence. An added benefit is that our mobile phlebotomy team and courier services will now have a single specimen drop off-site instead of multiple locations. Increasing the capacities of our laboratory not only supports our geographic market expansion and testing services growth but with the expanded laboratory facility, MCL is positioned to participate in additional research and development opportunities as we will have research space and are near the Cummings Research Park,” Crespo stated.


    Phase 1 of the Huntsville Lab expansion and Madison integration will be completed by the end of April. Phase II, the addition of administrative offices, is to be finalized by mid-to-late summer 2022.


    MCL started patient testing in January 2016 in its Madison, Alabama location with a focus on meeting the laboratory needs dedicated to the elderly and long-term care patients. The Company acquired a pharmacogenomics lab in Huntsville in 2018 to expand its lab test menu and quickly pivoted to comprehensive pathogen detection using state-of-the-art molecular technologies. Over the past three years, MCL has rapidly become a major local/regional laboratory through diverse test offerings.


    Madison Core Laboratories would like to thank the City of Madison for supporting a small business during its growth and looks forward to continuing to serve its community from the Huntsville Lab location at 2705 Artie Street SW in Huntsville, Alabama. Construction and move activities are planned to ensure no disruption in testing services will occur.


    About Madison Core Laboratories

    Madison Core Laboratories is one of the leading independent laboratories in Alabama. We provide extensive laboratory services using state-of-the-art testing equipment to provide our clients with the latest innovations in the laboratory spectrum. Our clients include physician offices, long-term care facilities, assisted living facilities, homebound patients, and industrial/corporate testing needs. MCL is the only independent reference laboratory in the State of Alabama that offers mobile phlebotomy, molecular diagnostics, routine blood, urine, and toxicology testing all under one organization. The Company was recently recognized by Inc. Magazine as one of the Fastest-Growing Private Companies in the Southeast Region.

    Learn more at Follow us on FacebookLinkedIn, or Twitter @MadisonCoreLabs.

    Company Contact:

    Madison Core Laboratories, LLC

    Martha Donze

    Vice President, Strategy and Business Operations


<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
100 Drake Dr., Unit 688
Normal, AL 35762

© BIO Alabama

Powered by Wild Apricot Membership Software